tiprankstipranks
Trending News
More News >
COSCIENS Biopharma (TSE:CSCI)
TSX:CSCI
Canadian Market
Advertisement

COSCIENS Biopharma (CSCI) Technical Analysis

Compare
39 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
COSCIENS Biopharma’s (CSCI) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting COSCIENS Biopharma is a Sell.
COSCIENS Biopharma’s (CSCI) 20-Day exponential moving average is 4.93, while COSCIENS Biopharma’s (CSCI) share price is C$5.42, making it a Buy.
COSCIENS Biopharma’s (CSCI) 50-Day exponential moving average is 4.81, while COSCIENS Biopharma’s (CSCI) share price is C$5.42, making it a Buy.

COSCIENS Biopharma (CSCI) Pivot Points

Jul 19, 2025, 03:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.86
5.01
5.21
5.36
5.56
5.71
5.91
Fibonacci
5.01
5.14
5.22
5.36
5.49
5.57
5.71
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

COSCIENS Biopharma (CSCI) Moving Averages

Jul 19, 2025, 03:01 AM
Period
Simple
Exponential
MA5
5.15Buy
5.29Buy
MA10
4.96Buy
5.07Buy
MA20
4.79Buy
4.93Buy
MA50
4.87Buy
4.81Buy
MA100
4.60Buy
4.72Buy
MA200
4.48Buy
4.92Buy
COSCIENS Biopharma’s (CSCI) 10-Day exponential moving average is 5.07, while COSCIENS Biopharma’s (CSCI) share price is C$5.42, making it a Buy.
COSCIENS Biopharma’s (CSCI) 100-Day exponential moving average is 4.72, while COSCIENS Biopharma’s (CSCI) share price is C$5.42, making it a Buy.
COSCIENS Biopharma’s (CSCI) stock price is C$5.42 and COSCIENS Biopharma’s (CSCI) 50-day simple moving average is 4.87, creating a Buy signal.
COSCIENS Biopharma’s (CSCI) stock price is C$5.42 and COSCIENS Biopharma’s (CSCI) 100-day simple moving average is 4.60, creating a Buy signal.
COSCIENS Biopharma’s (CSCI) stock price is C$5.42 and COSCIENS Biopharma’s (CSCI) 200-day simple moving average is 4.48, creating a Buy signal.

COSCIENS Biopharma (CSCI) Technical Indicators

Jul 19, 2025, 03:01 AM
Name
Value
Implied Action
RSI (14)
74.94
Sell
STOCH (9,6)
81.37
Sell
STOCHRSI (14)
83.73
Sell
MACD (12,26)
0.13
Sell
ADX (14)
26.35
Neutral
Williams %R
-13.51
Sell
CCI (14)
358.25
Sell
ATR (14)
0.26
-
Ultimate Oscillator
57.13
Neutral
ROC
28.04
Buy
COSCIENS Biopharma’s (CSCI) Relative Strength Index (RSI) is 74.94, creating a Sell signal.
COSCIENS Biopharma’s (CSCI) Trend Strength Indicator (ADX) is 26.35, creating a Neutral signal.
COSCIENS Biopharma’s (CSCI) Commodity Channel Index (CCI) is 358.25, creating a Sell signal.
COSCIENS Biopharma’s (CSCI) Price Rate of Change (ROC) is 28.04, creating a Buy signal.

FAQ

Is CSCI a Buy, Hold, or Sell?
Based on CSCI’s technical indicators, CSCI is a Buy.
    What is CSCI’s RSI (14)?
    CSCI’s RSI (14) is 74.94, which suggests CSCI is a Sell.
      What is CSCI’s MACD?
      CSCI’s MACD is 0.13, which suggests CSCI is a Sell.
        What is CSCI’s 5-day moving average?
        CSCI’s 5-day moving average is 5.15, which suggests CSCI is a Buy.
          What is CSCI’s 20-day moving average?
          CSCI 20-day moving average is 4.79, which suggests CSCI is a Buy.
            What is CSCI’s 50-day moving average?
            CSCI’s 50-day moving average is 4.87, which suggests CSCI is a Buy.
              What is CSCI’s 200-day moving average?
              CSCI’s 200-day moving average is 4.48, which suggests CSCI is a Buy.
                What is CSCI’s Williams % R (14)?
                CSCI’s Williams % R (14) is -13.51, which suggests CSCI is a Sell.
                  What is CSCI’s CCI (14)?
                  CSCI’s CCI (14) is 358.25, which suggests CSCI is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis